화일약품

061250KOSDAQView the 제약 sectorTheme Bio & healthcare

5,790KRWMarket close of 10/28 (Wed)

Up +0.70%+40KRWMarket close of 10/28 (Wed)

Open
5,800
High
5,800
Low
5,660
Day range
Day range low 5,660 high 5,800, open 5,800, close 5,790, previous close 5,750
Volume
1×10K shares
31.24 million KRW 0.50× the 20-session average

Market close of 10/28 (Wed)

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/28 (Wed)
Market close data of 2026-10-28

Points to check

  • Earningsnot verifiedThe last four quarters are incomplete, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 2 are within the usual range

  • Daily move+0.70%usual range
  • Trading value0.5×usual range

With 118 trading days, the 1-year position isn't calculated · First data date 5/4 (Mon)

See the full check report

Filings in the last 2 years · 1

Annual reportHalf-year reportQuarterly reportMaterial eventAmended

Material events are checked for the top 400 stocks only — this stock shows periodic reports only.

  1. 2026-08-13Half-year report (2026.06)

Same sector · 제약

Up +0.44%

· 100 of 169 stocks up, preferred shares excluded · trading value 566.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +6.1%Up +0.64%80.0B KRW
삼성바이오로직스Close over the last 20 sessions -0.9%Down -0.15%68.9B KRW
파마리서치Close over the last 20 sessions -27.8%Down -1.30%43.9B KRW
한미약품Close over the last 20 sessions -27.1%Up +5.42%42.3B KRW
삼익제약Close over the last 20 sessions -13.1%Up +9.54%34.5B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 18 days
  • Next data 10/30 (Fri) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 83% of trading value, about 93% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.